INNOVO by Atlantic Therapeutics

01 / WHAT IT BUILT

What the company did

INNOVO was the flagship product of Atlantic Therapeutics, a Galway, Ireland-based medical device company spun out of Bio-medical Research Group (BMR) in 2017. INNOVO is a non-invasive pelvic floor strengthening device that treats stress urinary incontinence: worn like a pair of exercise shorts, it uses neuromuscular electrical stimulation (NMES) technology to deliver 180 pelvic floor contractions in a 30-minute at-home session, strengthening and re-educating the muscles. It became the first transcutaneous electrical stimulator cleared by the FDA as a safe, clinically effective treatment for stress urinary incontinence in November 2018, and was sold directly to consumers with starter kits priced around €399.

03 / EVENT HISTORY

Events in the structured record

1. 2017
   Company spun out

   Atlantic Therapeutics spins out of BMR in Galway and raises €15 million in growth financing led by Seroba Life Sciences and Earlybird to expand its INNOVO technology.

2. 2018
   FDA clearance

   The INNOVO device becomes the first transcutaneous electrical stimulator cleared by the FDA as a safe, clinically effective, non-invasive treatment for stress urinary incontinence.

3. 2023
   Acquisition

   Caldera Medical, a women's health device company, completes its acquisition of Atlantic Therapeutics in October 2023 and adds the FDA-cleared INNOVO device family to its portfolio.